ProShare Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.4M | Sell |
34,560
-1,435
| -4% | -$532K | 0.02% | 329 |
|
|
2026
Q1 | $10.5M | Sell |
35,995
-7,162
| -17% | -$2.35M | 0.02% | 349 |
|
|
2025
Q4 | $15.1M | Buy |
43,157
+904
| +2% | +$305K | 0.03% | 301 |
|
|
2025
Q3 | $13.7M | Buy |
42,253
+2,025
| +5% | +$630K | 0.03% | 312 |
|
|
2025
Q2 | $15.6M | Buy |
40,228
+3,455
| +9% | +$1.39M | 0.03% | 295 |
|
|
2025
Q1 | $16M | Buy |
36,773
+1,670
| +5% | +$670K | 0.04% | 282 |
|
|
2024
Q4 | $12.9M | Buy |
35,103
+3,828
| +12% | +$1.6M | 0.03% | 293 |
|
|
2024
Q3 | $16.3M | Sell |
31,275
-2,514
| -7% | -$1.34M | 0.04% | 272 |
|
|
2024
Q2 | $18.3M | Sell |
33,789
-692
| -2% | -$366K | 0.05% | 253 |
|
|
2024
Q1 | $17.9M | Sell |
34,481
-851
| -2% | -$423K | 0.05% | 253 |
|
|
2023
Q4 | $16.7M | Sell |
35,332
-3,926
| -10% | -$1.82M | 0.05% | 252 |
|
|
2023
Q3 | $17.1M | Sell |
39,258
-2,530
| -6% | -$1.15M | 0.05% | 247 |
|
|
2023
Q2 | $18.6M | Buy |
41,788
+191
| +0.5% | +$88.1K | 0.05% | 247 |
|
|
2023
Q1 | $19.1M | Buy |
41,597
+8,654
| +26% | +$4.12M | 0.06% | 243 |
|
|
2022
Q4 | $16.9M | Sell |
32,943
-294
| -0.9% | -$149K | 0.06% | 234 |
|
|
2022
Q3 | $15.1M | Sell |
33,237
-3,918
| -11% | -$1.87M | 0.06% | 241 |
|
|
2022
Q2 | $17.9M | Sell |
37,155
-14,782
| -28% | -$7.31M | 0.06% | 245 |
|
|
2022
Q1 | $25.5M | Sell |
51,937
-1,451
| -3% | -$663K | 0.05% | 220 |
|
|
2021
Q4 | $24.7M | Buy |
53,388
+11,677
| +28% | +$4.91M | 0.05% | 218 |
|
|
2021
Q3 | $15.6M | Sell |
41,711
-1,159
| -3% | -$440K | 0.04% | 286 |
|
|
2021
Q2 | $16.4M | Buy |
42,870
+6,902
| +19% | +$2.64M | 0.05% | 280 |
|
|
2021
Q1 | $12.9M | Sell |
35,968
-34
| -0.1% | -$10.9K | 0.04% | 309 |
|
|
2020
Q4 | $11.6M | Buy |
36,002
+2,974
| +9% | +$913K | 0.04% | 282 |
|
|
2020
Q3 | $8.87M | Buy |
33,028
+2,745
| +9% | +$739K | 0.04% | 280 |
|
|
2020
Q2 | $7.96M | Buy |
30,283
+3,881
| +15% | +$1.04M | 0.04% | 286 |
|
|
2020
Q1 | $5.99M | Sell |
26,402
-18,172
| -41% | -$4.95M | 0.04% | 323 |
|
|
2019
Q4 | $13.5M | Buy |
44,574
+8,812
| +25% | +$2.42M | 0.06% | 274 |
|
|
2019
Q3 | $8.59M | Buy |
35,762
+1,898
| +6% | +$520K | 0.05% | 340 |
|
|
2019
Q2 | $9.56M | Sell |
33,864
-7,565
| -18% | -$2.07M | 0.06% | 312 |
|
|
2019
Q1 | $11.9M | Buy |
41,429
+1,743
| +4% | +$504K | 0.07% | 228 |
|
|
2018
Q4 | $10.4M | Sell |
39,686
-4,853
| -11% | -$1.33M | 0.07% | 210 |
|
|
2018
Q3 | $12.2M | Sell |
44,539
-4,531
| -9% | -$1.18M | 0.08% | 187 |
|
|
2018
Q2 | $11.7M | Sell |
49,070
-2,324
| -5% | -$538K | 0.08% | 199 |
|
|
2018
Q1 | $11.3M | Buy |
51,394
+1,433
| +3% | +$337K | 0.07% | 212 |
|
|
2017
Q4 | $11.2M | Buy |
49,961
+8,033
| +19% | +$1.71M | 0.08% | 215 |
|
|
2017
Q3 | $7.96M | Buy |
41,928
+918
| +2% | +$175K | 0.07% | 265 |
|
|
2017
Q2 | $7.71M | Sell |
41,010
-312
| -0.8% | -$56.1K | 0.08% | 245 |
|
|
2017
Q1 | $6.83M | Buy |
41,322
+266
| +0.6% | +$42.3K | 0.07% | 278 |
|
|
2016
Q4 | $5.9M | Buy |
41,056
+8,624
| +27% | +$1.15M | 0.07% | 299 |
|
|
2016
Q3 | $4.06M | Sell |
32,432
-10,640
| -25% | -$1.37M | 0.06% | 278 |
|
|
2016
Q2 | $5.66M | Buy |
43,072
+484
| +1% | +$66.2K | 0.07% | 214 |
|
|
2016
Q1 | $5.92M | Sell |
42,588
-17,976
| -30% | -$2.4M | 0.08% | 217 |
|
|
2015
Q4 | $8.45M | Buy |
60,564
+15,047
| +33% | +$2.07M | 0.1% | 194 |
|
|
2015
Q3 | $6.37M | Buy |
45,517
+1,249
| +3% | +$188K | 0.09% | 232 |
|
|
2015
Q2 | $7.27M | Sell |
44,268
-7,613
| -15% | -$1.22M | 0.1% | 208 |
|
|
2015
Q1 | $8.01M | Sell |
51,881
-16,108
| -24% | -$2.29M | 0.09% | 217 |
|
|
2014
Q4 | $8.54M | Buy |
67,989
+4,920
| +8% | +$608K | 0.1% | 217 |
|
|
2014
Q3 | $7.54M | Sell |
63,069
-3,460
| -5% | -$397K | 0.1% | 194 |
|
|
2014
Q2 | $7.16M | Sell |
66,529
-5,658
| -8% | -$583K | 0.09% | 202 |
|
|
2014
Q1 | $7.19M | Buy |
72,187
+1,160
| +2% | +$105K | 0.09% | 192 |
|
|
2013
Q4 | $6.56M | Buy |
71,027
+26,040
| +58% | +$2.31M | 0.1% | 208 |
|
|
2013
Q3 | $3.76M | Sell |
44,987
-13,637
| -23% | -$1.17M | 0.09% | 181 |
|
|
2013
Q2 | $4.8M | Buy |
+58,624
| New | +$4.39M | 0.09% | 194 |
|
Other funds holding ELV
ProShare Advisors's ELV Position: Q2 2026 in Review
ProShare Advisors reduced its Elevance Health (ELV) stake by 4% in Q2 2026, selling an estimated $532K and leaving 34,560 shares worth $13.4M. The position accounts for 0.02% of the portfolio, ranked #329.
ProShare Advisors first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.5M in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- ProShare Advisors held 34,560 shares of Elevance Health worth $13.4M as of Q2 2026.
- ProShare Advisors sold 1,435 Elevance Health shares in Q2 2026, an estimated $532K.
- Elevance Health made up 0.02% of ProShare Advisors's portfolio in Q2 2026, its #329 holding.
- ProShare Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- ProShare Advisors's Elevance Health position peaked at $25.5M in Q1 2022.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.